| Literature DB >> 29474920 |
Vincenzo A Gennarino1, Elizabeth E Palmer2, Laura M McDonell3, Li Wang4, Carolyn J Adamski5, Amanda Koire6, Lauren See7, Chun-An Chen4, Christian P Schaaf4, Jill A Rosenfeld7, Jessica A Panzer8, Ute Moog9, Shuang Hao10, Ann Bye11, Edwin P Kirk12, Pawel Stankiewicz13, Amy M Breman13, Arran McBride3, Tejaswi Kandula11, Holly A Dubbs14, Rebecca Macintosh15, Michael Cardamone11, Ying Zhu16, Kevin Ying17, Kerith-Rae Dias17, Megan T Cho18, Lindsay B Henderson18, Berivan Baskin18, Paula Morris17, Jiang Tao19, Mark J Cowley19, Marcel E Dinger19, Tony Roscioli20, Oana Caluseriu21, Oksana Suchowersky22, Rani K Sachdev11, Olivier Lichtarge7, Jianrong Tang10, Kym M Boycott3, J Lloyd Holder10, Huda Y Zoghbi23.
Abstract
Certain mutations can cause proteins to accumulate in neurons, leading to neurodegeneration. We recently showed, however, that upregulation of a wild-type protein, Ataxin1, caused by haploinsufficiency of its repressor, the RNA-binding protein Pumilio1 (PUM1), also causes neurodegeneration in mice. We therefore searched for human patients with PUM1 mutations. We identified eleven individuals with either PUM1 deletions or de novo missense variants who suffer a developmental syndrome (Pumilio1-associated developmental disability, ataxia, and seizure; PADDAS). We also identified a milder missense mutation in a family with adult-onset ataxia with incomplete penetrance (Pumilio1-related cerebellar ataxia, PRCA). Studies in patient-derived cells revealed that the missense mutations reduced PUM1 protein levels by ∼25% in the adult-onset cases and by ∼50% in the infantile-onset cases; levels of known PUM1 targets increased accordingly. Changes in protein levels thus track with phenotypic severity, and identifying posttranscriptional modulators of protein expression should identify new candidate disease genes.Entities:
Keywords: Ataxin-1; PADDAS; PRCA; Pumilio1; RNA-binding proteins; ataxia; chromosome 1p35.2; copy number variants; developmental delay; intellectual disability; seizures
Mesh:
Substances:
Year: 2018 PMID: 29474920 PMCID: PMC5832058 DOI: 10.1016/j.cell.2018.02.006
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 66.850